In vitro and in vivo experiments confirm that ZHX2 significantly inhibits HBc, HBsAg, and HBeAg expression (25), while overexpression of ZHX2 eliminates HBx-mediated proliferation of HCC cells (48). Here, ZHX2 is linked to hepatocellular carcinoma.